Pharmaceutical company Lupin on Monday announced that it has launched its generic Thiamine Hydrochloride injection 200 mg/2 mL (100 mg/mL) multiple-dose vials used for treatment of thiamine deficiency in the US. The launch follows alliance partner Caplin Steriles receiving an approval for its ANDA (Abbreviated New Drug Application) from the US Food and Drug Administration (USFDA).nnnRead more at:nhttps://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pharma-major-lupin-launches-injection-to-cure-thiamine-deficiency-in-us/articleshow/101101852.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
Enforcement Report - Week of February 22, 2023
Enforcement Report - Week Of June 01, 2022
Eugia Pharma's Generic Thiamine HCL Receives Approval in the U.S.
Enforcement Report- Week of June 9, 2021
Health Canada Issues Recall of Omega Laboratorie`s Thiamiject Injection
Sagent Pharm’s Generic Thiamine Hydrochloride Receives Approval In US
Anvisa suspends Dexadoze manufactured by Laboratorio Teuto Brasileiro S / A